176 related articles for article (PubMed ID: 12829635)
1. HIV protease inhibitors acutely impair glucose-stimulated insulin release.
Koster JC; Remedi MS; Qiu H; Nichols CG; Hruz PW
Diabetes; 2003 Jul; 52(7):1695-1700. PubMed ID: 12829635
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells.
Schütt M; Zhou J; Meier M; Klein HH
J Endocrinol; 2004 Dec; 183(3):445-54. PubMed ID: 15590971
[TBL] [Abstract][Full Text] [Related]
3. Direct interference of HIV protease inhibitors with pancreatic beta-cell function.
Düfer M; Neye Y; Krippeit-Drews P; Drews G
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):583-90. PubMed ID: 15197535
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets.
Ishihara H; Asano T; Tsukuda K; Katagiri H; Inukai K; Anai M; Kikuchi M; Yazaki Y; Miyazaki JI; Oka Y
Diabetologia; 1993 Nov; 36(11):1139-45. PubMed ID: 8270128
[TBL] [Abstract][Full Text] [Related]
5. [Effects of various HIV protease inhibitors on function of rat insulinoma cells].
Zhou JQ; Li WP; Xiang Z; Schutt M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 May; 35(3):251-4. PubMed ID: 16764025
[TBL] [Abstract][Full Text] [Related]
6. Indinavir induces acute and reversible peripheral insulin resistance in rats.
Hruz PW; Murata H; Qiu H; Mueckler M
Diabetes; 2002 Apr; 51(4):937-42. PubMed ID: 11916910
[TBL] [Abstract][Full Text] [Related]
7. Glucose-dependent modulation of insulin secretion and intracellular calcium ions by GKA50, a glucokinase activator.
Johnson D; Shepherd RM; Gill D; Gorman T; Smith DM; Dunne MJ
Diabetes; 2007 Jun; 56(6):1694-702. PubMed ID: 17360975
[TBL] [Abstract][Full Text] [Related]
8. HIV protease inhibitors: suppression of insulin secretion by inhibition of voltage-dependent K+ currents and anion currents.
Neye Y; Düfer M; Drews G; Krippeit-Drews P
J Pharmacol Exp Ther; 2006 Jan; 316(1):106-12. PubMed ID: 16162820
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of HIV protease inhibitors on adipogenesis: intracellular ritonavir is not sufficient to inhibit differentiation.
Vernochet C; Azoulay S; Duval D; Guedj R; Ailhaud G; Dani C
AIDS; 2003 Oct; 17(15):2177-80. PubMed ID: 14523274
[TBL] [Abstract][Full Text] [Related]
10. HIV protease inhibitors block adipogenesis and increase lipolysis in vitro.
Lenhard JM; Furfine ES; Jain RG; Ittoop O; Orband-Miller LA; Blanchard SG; Paulik MA; Weiel JE
Antiviral Res; 2000 Aug; 47(2):121-9. PubMed ID: 10996400
[TBL] [Abstract][Full Text] [Related]
11. The long-term effects of anti-retroviral protease inhibitors on sugar transport in L6 cells.
Germinario RJ; Colby-Germinario SP; Cammalleri C; Wainberg MA
J Endocrinol; 2003 Sep; 178(3):449-56. PubMed ID: 12967347
[TBL] [Abstract][Full Text] [Related]
12. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study.
Noor MA; Seneviratne T; Aweeka FT; Lo JC; Schwarz JM; Mulligan K; Schambelan M; Grunfeld C
AIDS; 2002 Mar; 16(5):F1-8. PubMed ID: 11964551
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antiadipogenic effects of HIV type 1 protease inhibitors with tumor necrosis factor alpha: suppression of extracellular insulin action mediated by extracellular matrix-degrading proteases.
Mondal D; Larussa VF; Agrawal KC
AIDS Res Hum Retroviruses; 2001 Nov; 17(17):1569-84. PubMed ID: 11779345
[TBL] [Abstract][Full Text] [Related]
14. A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity.
Hertel J; Struthers H; Horj CB; Hruz PW
J Biol Chem; 2004 Dec; 279(53):55147-52. PubMed ID: 15496402
[TBL] [Abstract][Full Text] [Related]
15. GS-8374, a novel HIV protease inhibitor, does not alter glucose homeostasis in cultured adipocytes or in a healthy-rodent model system.
Hruz PW; Yan Q; Tsai L; Koster J; Xu L; Cihlar T; Callebaut C
Antimicrob Agents Chemother; 2011 Apr; 55(4):1377-82. PubMed ID: 21245443
[TBL] [Abstract][Full Text] [Related]
16. [Resistance to protease inhibitors].
Clotet B; Martínez-Picado J; Arrizabalaga J; Ruiz L
Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):34-41. PubMed ID: 11428058
[No Abstract] [Full Text] [Related]
17. Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers.
Lee GA; Rao M; Mulligan K; Lo JC; Aweeka F; Schwarz JM; Schambelan M; Grunfeld C
AIDS; 2007 Oct; 21(16):2183-90. PubMed ID: 18090045
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro.
Granfors MT; Wang JS; Kajosaari LI; Laitila J; Neuvonen PJ; Backman JT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):79-85. PubMed ID: 16433896
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance in HIV protease inhibitor-associated diabetes.
Yarasheski KE; Tebas P; Sigmund C; Dagogo-Jack S; Bohrer A; Turk J; Halban PA; Cryer PE; Powderly WG
J Acquir Immune Defic Syndr; 1999 Jul; 21(3):209-16. PubMed ID: 10421244
[TBL] [Abstract][Full Text] [Related]
20. Glucose uptake, utilization, and signaling in GLUT2-null islets.
Guillam MT; Dupraz P; Thorens B
Diabetes; 2000 Sep; 49(9):1485-91. PubMed ID: 10969832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
